Physician profile
Kevin K Lee
NPI 1649213208
$2,588.66
in general payments reported to CMS, 2019-2025
17 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2020: $48.17 · 2021: $1,100 · 2022: $150 · 2023: $134 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $954.73 | 2020-2023 | Accutrac |
| Olympus Corporation of The Americas | $525.82 | 2019 | |
| Astellas Pharma US INC | $410.93 | 2019-2021 | |
| Calyxo, INC. | $175.60 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $102.00 | 2022 | |
| Pfizer INC. | $76.40 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.32 | 2021 | |
| Coloplast Corp | $60.74 | 2019-2021 | |
| Janssen Biotech, INC. | $53.73 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $44.40 | 2025 | Erleada, Pipeline |
| Sumitomo Pharma America, INC. | $24.96 | 2023 | Gemtesa |
| Urogen Pharma, INC. | $17.33 | 2022 | |
| Myovant Sciences INC. | $17.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.65 | 2019 | |
| Medtronic, INC. | $16.64 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $15.77 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.